Fecal Microbiota Transplantation for Irritable Bowel Syndrome Associated Food Intolerance

Previous studies have shown that stool transplantation (FMT) have positive effect in symptoms for some patients with irritable bowel syndrome (IBS). Studies have shown that it is possible by FMT to reverse the microbiome of the recipient's intestine in the direction of the microbiome of the donor. The effect on eating habits for engraftment of microbiome by FMT is unknown. The purpose of this study is to investigate whether FMT relieves FODMAP diet extension without worsening intestinal symptoms in IBS patients.

NCT Number	NCT05361785
Lead Sponsor	Helsinki University Central Hospital Collaborators: Turku University Hospital, University of Helsinki, Paijat-Hame Hospital District
Conditions	Irritable Bowel Syndrome, Fecal Microbiota Transplantation
Enrollment	45 participants
Start Date	2022-04-30
Primary Completion	2024-07-31 (estimated)
Study Completion	2026-07-31 (estimated)
Updated on ClinicalTrials.gov	2022-05-13